中/EN Contact/Message
  • Home
  • central pharmacy
  • Policies
  • Medical Institution
  • Franchise
  • Innovate
  • Recruit
  • News
  • Home
  • central pharmacy
  • Policies
  • Medical Institution
  • Franchise
  • Innovate
  • Recruit
  • News
  • 中/EN
  • Contact/Message
    • Innovate
    Your current position：
    Columvi
    Columvi
    departments：肿瘤科
    drug：注射液
    Active：Glofitamab
    indication：复发性或难治性弥漫性大B细胞淋巴瘤
    Licensor：Roche Registration GmbH
    Approved Country/Region：欧盟
    Approval time：2023-07-07